Best Performing Stocks
Stocks that have climbed the most from their 52-week low. The year's biggest winners — momentum that's already proven itself.
200 stocks
Updated Nov 7, 2026
+0.00%
Avg Daily Change
$86.29
Avg Share Price
$2.85 – $1,414.06
Price Range
$11.58T
Total Market Cap
The best performing stocks are companies that have delivered the largest gains from their 52-week low, representing proven momentum over a sustained period. Unlike daily gainers that may spike on a single headline, these stocks have built a track record of consistent upward movement over months, driven by strong fundamentals, earnings beats, or sector-wide tailwinds.
Momentum investing — buying stocks that have already demonstrated strong price performance — is one of the most well-documented factors in finance. Academic research shows that stocks with high relative strength tend to continue outperforming over the following 3-12 months before eventually reverting. The key risk is buying at the tail end of a run when most of the upside has already been captured.
This list ranks stocks by their percentage gain from the 52-week low, filtered to companies with at least $1 billion in market cap. All data including current prices, 52-week ranges, and market caps is updated throughout the trading day. Only stocks that have risen at least 50% from their 52-week low are included.
| # | Symbol | Name | Price | 52W Return | 52W Low | 52W High | Market Cap |
|---|---|---|---|---|---|---|---|
| 1 | MGRT | Mega Fortune Co Ltd | $118.63 | +2,836.4% | $4.04 | $170.00 | 1.62B |
| 2 | SLN | Silence Therapeutics PLC | $19.72 | +1,760.4% | $1.06 | $6.38 | 1.28B |
| 3 | AGL | Agilon Health Inc | $112.19 | +1,399.9% | $7.48 | $133.04 | 1.90B |
| 4 | REPL | Replimune Group Inc | $17.61 | +1,074.0% | $1.50 | $21.26 | 2.00B |
| 5 | MRNA | Moderna Inc | $254.19 | +1,040.9% | $22.28 | $261.00 | 105.54B |
| 6 | SGAPY | Singapore Airlines Limited | $32.94 | +797.5% | $3.67 | $5.27 | 79.84B |
| 7 | WLMIY | Wilmar International | $23.27 | +737.1% | $2.78 | $4.02 | 24.03B |
| 8 | FBRX | Forte Biosciences Inc | $76.99 | +647.5% | $10.30 | $77.20 | 1.63B |
| 9 | ERAS | Erasca Inc | $14.41 | +584.6% | $2.11 | $24.28 | 5.04B |
| 10 | KOD | Kodiak Sciences Inc | $98.51 | +522.3% | $15.83 | $104.00 | 6.17B |
| 11 | AXTI | Axt Inc | $48.20 | +517.2% | $7.81 | $143.16 | 2.48B |
| 12 | SLS | Sellas Life Sciences Group I | $7.88 | +466.9% | $1.39 | $15.88 | 1.61B |
| 13 | CDNA | Caredx Inc | $78.56 | +444.8% | $14.42 | $90.87 | 4.01B |
| 14 | DBSDY | DBS Group Holdings Ltd | $217.86 | +431.6% | $40.98 | $60.00 | 162.83B |
| 15 | MXL | Maxlinear Inc | $67.47 | +428.3% | $12.77 | $128.30 | 4.27B |
| 16 | TWST | Twist Bioscience Corp | $120.79 | +418.4% | $23.30 | $219.71 | 7.69B |
| 17 | SYRE | Spyre Therapeutics Inc | $103.14 | +387.8% | $21.15 | $110.18 | 9.75B |
| 18 | PACS | Pacs Group Inc | $49.93 | +384.3% | $10.31 | $51.68 | 7.97B |
| 19 | TXG | 10X Genomics Inc-Class A | $58.91 | +360.2% | $12.80 | $102.81 | 7.28B |
| 20 | IOVA | Iovance Biotherapeutics Inc | $8.04 | +356.8% | $1.76 | $15.37 | 3.62B |
| 21 | SNDK | Sandisk Corp | $835.06 | +356.3% | $183.00 | $2,354.39 | 114.75B |
| 22 | UOLGY | UOL Group Limited | $25.20 | +355.7% | $5.53 | $11.48 | 8.64B |
| 23 | ABSI | Absci Corp | $10.17 | +354.0% | $2.24 | $12.54 | 1.75B |
| 24 | GLTO | Galecto Inc | $22.41 | +352.7% | $4.95 | $38.33 | 1.73B |
| 25 | IBRX | Immunitybio Inc | $8.55 | +338.5% | $1.95 | $12.43 | 8.69B |
| 26 | MANE | Veradermics Inc | $138.78 | +333.7% | $32.00 | $80.90 | 2.77B |
| 27 | TOP | Top Financial Group Ltd A | $13.25 | +333.0% | $3.06 | $17.42 | 1.64B |
| 28 | ABCL | Abcellera Biologics Inc | $11.88 | +332.8% | $2.75 | $15.02 | 3.85B |
| 29 | ACGBY | Agricultural Bank of China | $21.77 | +325.9% | $5.11 | $8.68 | 2.40T |
| 30 | CYCN | Cyclerion Therapeutics Inc | $30.56 | +325.0% | $7.19 | $59.36 | 1.55B |
| 31 | PLSE | Pulse Biosciences Inc | $53.07 | +322.5% | $12.56 | $58.90 | 3.82B |
| 32 | TERN | Terns Pharmaceuticals Inc | $52.95 | +314.6% | $12.77 | $53.19 | 6.12B |
| 33 | ETON | Eton Pharmaceuticals Inc | $56.46 | +295.7% | $14.27 | $66.37 | 1.63B |
| 34 | ATEX | Anterix Inc | $68.52 | +289.8% | $17.58 | $113.00 | 1.48B |
| 35 | DRTS | Alpha Tau Medical Ltd | $13.30 | +287.8% | $3.43 | $15.79 | 1.21B |
| 36 | HNGE | Hinge Health Inc-A | $115.76 | +284.8% | $30.08 | $124.94 | 9.36B |
| 37 | ORKA | Oruka Therapeutics Inc | $96.87 | +283.9% | $25.23 | $115.52 | 6.36B |
| 38 | BACHY | Bank of China Limited | $19.23 | +274.9% | $5.13 | $6.39 | 1.72T |
| 39 | ANDG | Andersen Group Inc - A | $65.19 | +259.8% | $18.12 | $68.41 | 7.49B |
| 40 | MU | Micron Technology Inc | $690.00 | +258.3% | $192.59 | $1,255.00 | 773.08B |
| 41 | KOS | Kosmos Energy Ltd | $2.85 | +239.3% | $0.84 | $3.34 | 1.31B |
| 42 | XNCR | Xencor Inc | $35.03 | +237.6% | $10.38 | $35.81 | 2.36B |
| 43 | ELVN | Enliven Therapeutics Inc | $49.28 | +233.3% | $14.79 | $62.32 | 3.57B |
| 44 | RVMD | Revolution Medicines Inc | $192.28 | +231.5% | $58.00 | $224.31 | 41.37B |
| 45 | IBTA | Ibotta Inc-Cl A | $63.18 | +230.8% | $19.10 | $66.39 | 1.36B |
| 46 | AMC | Amc Entertainment Hlds-Cl A | $3.06 | +229.0% | $0.93 | $3.77 | 2.75B |
| 47 | AEHR | Aehr Test Systems | $60.84 | +225.3% | $18.70 | $147.40 | 1.70B |
| 48 | VSCO | Victoria'S Secret & Co | $108.95 | +224.2% | $33.61 | $109.82 | 5.90B |
| 49 | PRCH | Porch Group Inc | $20.56 | +223.3% | $6.36 | $21.96 | 2.26B |
| 50 | BAND | Bandwidth Inc-Class A | $40.34 | +222.7% | $12.50 | $79.08 | 1.28B |
| 51 | PURR | Hyperliquid Strategies | $9.69 | +221.9% | $3.01 | $14.76 | 3.42B |
| 52 | XMTR | Xometry Inc-A | $114.95 | +220.6% | $35.86 | $117.50 | 6.24B |
| 53 | BFLY | Butterfly Network Inc | $6.07 | +219.5% | $1.90 | $10.21 | 1.62B |
| 54 | PSNL | Personalis Inc | $15.82 | +219.3% | $4.96 | $18.89 | 1.70B |
| 55 | DFTX | Definium Therapeutics Inc | $33.28 | +218.0% | $10.47 | $49.70 | 4.43B |
| 56 | AMN | Amn Healthcare Services Inc | $47.42 | +216.8% | $14.97 | $49.62 | 1.43B |
| 57 | NAVN | Navan Inc-Cl A | $25.42 | +213.6% | $8.11 | $30.88 | 6.63B |
| 58 | APPS | Digital Turbine Inc | $8.46 | +208.8% | $2.74 | $15.34 | 1.18B |
| 59 | ICLR | Icon Plc | $204.74 | +207.6% | $66.57 | $219.04 | 15.29B |
| 60 | ECPG | Encore Capital Group Inc | $126.17 | +207.0% | $41.10 | $126.74 | 2.68B |
| 61 | U | Unity Software Inc | $51.49 | +206.9% | $16.78 | $52.15 | 20.94B |
| 62 | ASST | Strive Inc-A | $21.45 | +205.6% | $7.02 | $34.40 | 2.73B |
| 63 | SEZL | Sezzle Inc | $150.99 | +205.0% | $49.50 | $195.71 | 5.24B |
| 64 | MRVI | Maravai Lifesciences Hldgs-A | $7.72 | +203.3% | $2.55 | $9.42 | 1.95B |
| 65 | AMPL | Amplitude Inc-Class A | $16.70 | +203.1% | $5.51 | $17.84 | 2.09B |
| 66 | DAWN | Day One Biopharmaceuticals I | $21.53 | +203.0% | $7.11 | $21.53 | 2.22B |
| 67 | RLAY | Relay Therapeutics Inc | $18.03 | +203.0% | $5.95 | $21.27 | 3.97B |
| 68 | VOR | Vor Biopharma Inc | $19.68 | +202.8% | $6.50 | $26.00 | 1.03B |
| 69 | RNG | Ringcentral Inc-Class A | $72.55 | +200.5% | $24.14 | $98.14 | 6.28B |
| 70 | BRZE | Braze Inc-A | $45.82 | +200.3% | $15.26 | $46.20 | 5.20B |
| 71 | DELL | Dell Technologies -C | $328.53 | +198.1% | $110.22 | $595.51 | 208.65B |
| 72 | IDCBY | Industrial & Commercial Bank of China | $20.16 | +197.7% | $6.77 | $8.40 | 2.54T |
| 73 | GRAL | Grail Inc | $121.44 | +192.6% | $41.50 | $166.48 | 5.32B |
| 74 | TNGX | Tango Therapeutics Inc | $21.56 | +192.5% | $7.37 | $34.39 | 3.62B |
| 75 | VIA | Via Transportation Inc-Cl A | $37.73 | +191.4% | $12.95 | $53.76 | 3.20B |
| 76 | MAAS | Maase Inc-A | $10.18 | +190.0% | $3.51 | $24.90 | 4.68B |
| 77 | LFST | Lifestance Health Group Inc | $13.87 | +189.6% | $4.79 | $15.66 | 5.26B |
| 78 | CRSR | Corsair Gaming Inc | $12.86 | +187.1% | $4.48 | $14.98 | 1.35B |
| 79 | OSCR | Oscar Health Inc - Class A | $30.65 | +186.7% | $10.69 | $38.50 | 9.46B |
| 80 | PD | Pagerduty Inc | $16.23 | +184.7% | $5.70 | $18.06 | 1.25B |
| 81 | VSTS | Vestis Corp | $14.12 | +184.4% | $4.97 | $16.90 | 2.00B |
| 82 | CLOV | Clover Health Investments Co | $4.46 | +182.3% | $1.58 | $5.59 | 2.56B |
| 83 | CBRL | Cracker Barrel Old Country | $70.05 | +181.9% | $24.85 | $73.67 | 1.50B |
| 84 | IRDM | Iridium Communications Inc | $44.00 | +181.2% | $15.65 | $57.18 | 4.55B |
| 85 | GKOS | Glaukos Corp | $225.52 | +178.7% | $80.91 | $255.19 | 13.42B |
| 86 | APPN | Appian Corp-A | $51.89 | +178.5% | $18.63 | $56.38 | 3.73B |
| 87 | NSP | Insperity Inc | $51.69 | +178.4% | $18.57 | $55.90 | 1.89B |
| 88 | NTSK | Netskope Inc-Cl A | $21.30 | +177.9% | $7.67 | $26.71 | 8.85B |
| 89 | LIND | Lindblad Expeditions Holding | $31.57 | +177.7% | $11.37 | $38.85 | 2.18B |
| 90 | ICHR | Ichor Holdings Ltd | $38.90 | +176.7% | $14.06 | $113.58 | 1.14B |
| 91 | TEAM | Atlassian Corp-Cl A | $153.68 | +174.4% | $56.01 | $229.96 | 38.70B |
| 92 | CERT | Certara Inc | $12.18 | +173.7% | $4.45 | $12.25 | 1.84B |
| 93 | OMER | Omeros Corp | $17.07 | +173.6% | $6.24 | $21.24 | 1.24B |
| 94 | VSTM | Verastem Inc | $9.38 | +173.5% | $3.43 | $10.82 | 1.03B |
| 95 | FIGS | Figs Inc-Class A | $19.98 | +173.3% | $7.31 | $22.46 | 3.29B |
| 96 | SDGR | Schrodinger Inc | $29.82 | +172.5% | $10.95 | $33.78 | 2.26B |
| 97 | AAOI | Applied Optoelectronics Inc | $50.13 | +171.0% | $18.50 | $233.67 | 3.98B |
| 98 | SEPN | Septerna Inc | $47.35 | +169.8% | $17.55 | $51.10 | 2.21B |
| 99 | EWTX | Edgewise Therapeutics Inc | $45.04 | +169.7% | $16.70 | $48.51 | 4.89B |
| 100 | OKTA | Okta Inc | $168.69 | +169.2% | $62.66 | $235.00 | 30.15B |
Frequently Asked Questions
What makes a stock a top performer?
Top-performing stocks are typically driven by a combination of strong earnings growth, revenue acceleration, positive analyst revisions, and favorable sector trends. Companies that consistently beat earnings estimates by wide margins tend to see their stock prices appreciate steadily. Other drivers include new product launches, market share gains, margin expansion, and inclusion in major indices that force passive funds to buy. Macroeconomic tailwinds — like falling interest rates for growth stocks or rising commodity prices for energy — also play a significant role.
Should I buy stocks that have already gone up a lot?
Research supports buying momentum stocks, but with caveats. The momentum factor has been profitable across markets and time periods — stocks that outperformed over the past 6-12 months tend to continue outperforming. However, momentum stocks are vulnerable to sharp reversals when sentiment shifts or when they become overvalued relative to fundamentals. The safest approach is combining momentum with valuation discipline — buying strong performers that still trade at reasonable multiples relative to their growth rates.
What is the difference between momentum and value investing?
Momentum investing buys stocks with strong recent price performance, betting that trends persist. Value investing buys stocks trading below their intrinsic worth, betting the market will eventually recognize the gap. The two styles tend to alternate in leadership — momentum dominates in strong bull markets and trending sectors, while value outperforms during market rotations and recoveries from downturns. Many professional portfolios blend both factors for diversification across market regimes.
How long do stock rallies typically last?
Individual stock rallies vary widely, but research suggests that momentum persists for 3-12 months on average before fading. Stocks driven by fundamental improvements (earnings, revenue) tend to sustain gains longer than those driven by speculation or short squeezes. The strongest rallies occur when a company transitions from negative to positive earnings growth, enters a new market, or benefits from a structural industry shift. Beyond 12 months, stocks with extreme gains often experience mean reversion as valuations stretch too far.
What sectors produce the most top performers?
Technology and healthcare consistently produce the highest percentage of top-performing stocks due to their capacity for rapid growth and innovation cycles. In bull markets, consumer discretionary and communication services also feature prominently. During commodity booms, energy and materials stocks dominate the leaderboard. The key insight is that sector leadership rotates — the sectors producing the best performers in one year are rarely the same sectors leading the following year.
What is relative strength in stocks?
Relative strength (RS) measures a stock's price performance compared to a benchmark, typically the S&P 500. A stock with an RS rating of 90 means it has outperformed 90% of all stocks over a given period. High relative strength indicates persistent buying pressure and institutional accumulation. Many momentum-based strategies use RS as a primary screening criterion — buying stocks in the top 10-20% of relative strength and selling when they fall below the top 50%.
How to manage risk with high-performing stocks?
Risk management is critical because momentum stocks can reverse sharply. Use a trailing stop-loss of 15-25% to protect gains while allowing normal volatility. Position sizing matters — limit any single stock to 3-5% of your portfolio regardless of conviction. Take partial profits at predetermined levels rather than waiting for the perfect exit. Diversify across multiple momentum names in different sectors so that a reversal in one stock doesn't devastate your portfolio. Watch for deteriorating fundamentals as an early warning that momentum may fade.
More Stock Lists
↑
Near 52-Week High
Stocks within 10% of their annual high. Momentum plays that are outperforming the broader market. $1B+ companies only.
→
🚀
Today's Biggest Gainers
Stocks with the largest percentage gains in today's session. Momentum in action — earnings beats, upgrades, or breakout moves.
→
⇈
Fastest Revenue Growth
Companies growing revenue at 20%+ annually. High-growth businesses that are scaling fast. $1B+ market cap.
→
⇅
Most Volatile Stocks
Stocks with the widest 52-week trading range relative to their current price. High beta names that swing hard in both directions.
→
✓
Wall Street Strong Buys
The Street's top picks: stocks with a unanimous or near-unanimous Strong Buy consensus from at least 5 analysts. $1B+ companies.
→
🌱
Growth Stocks
Companies growing revenue at 10%+ per year with $1B+ market cap. The compounders that could become tomorrow's mega-caps.
→